Free Trial

Calidi Biotherapeutics (CLDI) SEC Filings & 10K Form

Calidi Biotherapeutics logo
$0.65 -0.05 (-6.53%)
Closing price 03/28/2025 04:00 PM Eastern
Extended Trading
$0.62 -0.03 (-3.85%)
As of 03/28/2025 08:00 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Recent Calidi Biotherapeutics SEC Filings

DateFilerForm TypeView
03/10/2025
4:21 PM
Calidi Biotherapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/10/2025
4:28 PM
Calidi Biotherapeutics (Filer)
Form 8-K/A
02/09/2025
11:15 PM
Calidi Biotherapeutics (Filer)
Form EFFECT
02/05/2025
5:27 AM
Calidi Biotherapeutics (Filer)
Form 424B5
01/28/2025
7:30 AM
Calidi Biotherapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/10/2025
3:58 PM
Calidi Biotherapeutics (Filer)
Form S-3
Registration statement under Securities Act of 1933  
01/10/2025
3:24 PM
Calidi Biotherapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/10/2025
7:30 AM
Calidi Biotherapeutics (Filer)
Form 424B5
01/10/2025
7:30 AM
Calidi Biotherapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/08/2025
3:01 PM
Calidi Biotherapeutics (Filer)
Form 424B5
01/03/2025
4:25 PM
Calidi Biotherapeutics (Issuer)
Leftwich Scott (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/03/2025
4:27 PM
Calidi Biotherapeutics (Issuer)
Stewart Alan R. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/29/2024
11:15 PM
Calidi Biotherapeutics (Filer)
Form EFFECT
12/18/2024
8:29 PM
Calidi Biotherapeutics (Issuer)
Camaisa Allan (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/12/2024
5:13 AM
Calidi Biotherapeutics (Filer)
Form S-1
Registration statement under Securities Act of 1933  
11/29/2024
4:00 PM
Calidi Biotherapeutics (Filer)
Form 424B5
11/18/2024
7:10 AM
Calidi Biotherapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/15/2024
4:02 PM
Calidi Biotherapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/15/2024
5:03 AM
Calidi Biotherapeutics (Filer)
Form 424B5
11/14/2024
5:21 AM
Calidi Biotherapeutics (Filer)
Form 424B5
11/12/2024
4:08 PM
Calidi Biotherapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
10/28/2024
9:05 AM
Calidi Biotherapeutics (Subject)
NYSE AMERICAN LLC (Filed by)
Form 25-NSE
10/24/2024
4:18 PM
Calidi Biotherapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/24/2024
8:38 AM
Calidi Biotherapeutics (Filer)
Form 424B5
10/23/2024
7:25 AM
Calidi Biotherapeutics (Filer)
Form 424B5
10/18/2024
4:25 PM
Calidi Biotherapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/18/2024
4:29 PM
Calidi Biotherapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/15/2024
8:14 PM
Calidi Biotherapeutics (Issuer)
Stewart Alan R. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/15/2024
8:14 PM
Calidi Biotherapeutics (Issuer)
Schoeneck James A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/15/2024
8:14 PM
Calidi Biotherapeutics (Issuer)
Peoples George (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/15/2024
8:14 PM
Calidi Biotherapeutics (Issuer)
Leftwich Scott (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/11/2024
4:05 PM
Calidi Biotherapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/10/2024
11:15 PM
Calidi Biotherapeutics (Filer)
Form EFFECT
09/30/2024
5:53 PM
Calidi Biotherapeutics (Issuer)
Camaisa Allan (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/30/2024
8:10 AM
Calidi Biotherapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/23/2024
5:10 PM
Calidi Biotherapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/12/2024
5:12 AM
Calidi Biotherapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/11/2024
3:04 PM
Calidi Biotherapeutics (Subject)
Funicular Funds, LP (Filed by)
Form SC 13G
08/22/2024
4:16 PM
Calidi Biotherapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/20/2024
5:04 AM
Calidi Biotherapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/13/2024
4:10 PM
Calidi Biotherapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
New “Trump” currency proposed in DC (Ad)

According to one of the most connected men in Washington… A surprising new bill was just introduced in Washington. Its purpose: to put Donald Trump’s face on the $100 note. All to celebrate a new “golden age” for America.

When you see what could happen – I think you’ll be excited.
07/29/2024
8:15 AM
Calidi Biotherapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/15/2024
3:58 PM
Calidi Biotherapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/11/2024
3:51 PM
Calidi Biotherapeutics (Issuer)
Peoples George (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
07/11/2024
3:53 PM
Calidi Biotherapeutics (Issuer)
Peoples George (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/08/2024
3:30 PM
Calidi Biotherapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/05/2024
3:30 PM
Calidi Biotherapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/02/2024
7:20 PM
Calidi Biotherapeutics (Issuer)
Schoeneck James A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/02/2024
7:22 PM
Calidi Biotherapeutics (Issuer)
Leftwich Scott (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/02/2024
7:12 PM
Calidi Biotherapeutics (Issuer)
Stewart Alan R. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/02/2024
7:14 PM
Calidi Biotherapeutics (Issuer)
Schoeneck James A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/02/2024
7:16 PM
Calidi Biotherapeutics (Issuer)
Leftwich Scott (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/02/2024
7:18 PM
Calidi Biotherapeutics (Issuer)
Stewart Alan R. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/26/2024
3:15 PM
Calidi Biotherapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/20/2024
7:56 PM
Calidi Biotherapeutics (Issuer)
Jackson Andrew C. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/20/2024
7:56 PM
Calidi Biotherapeutics (Issuer)
Campbell Wendy Pizarro (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/20/2024
7:56 PM
Calidi Biotherapeutics (Issuer)
Minev Boris Radoslavov (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/20/2024
7:56 PM
Calidi Biotherapeutics (Issuer)
Camaisa Allan (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/05/2024
3:15 PM
Calidi Biotherapeutics (Issuer)
Schoeneck James A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/04/2024
4:24 PM
Calidi Biotherapeutics (Filer)
Form 424B3
05/17/2024
3:35 PM
Calidi Biotherapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/16/2024
4:24 PM
Calidi Biotherapeutics (Filer)
Form 424B3
05/14/2024
8:01 PM
Calidi Biotherapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/14/2024
3:57 PM
Calidi Biotherapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/09/2024
4:00 PM
Calidi Biotherapeutics (Filer)
Form DEF 14A
05/01/2024
11:57 AM
Calidi Biotherapeutics (Subject)
Kessler Judd S (Filed by)
Form SCHEDULE 13D
04/19/2024
4:25 PM
Calidi Biotherapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/19/2024
4:20 PM
Calidi Biotherapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/18/2024
4:00 PM
Calidi Biotherapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/17/2024
3:15 PM
Calidi Biotherapeutics (Filer)
Form 424B4
04/16/2024
11:15 PM
Calidi Biotherapeutics (Filer)
Form EFFECT
04/15/2024
5:31 AM
Calidi Biotherapeutics (Filer)
Form S-1/A
04/08/2024
3:40 PM
Calidi Biotherapeutics (Filer)
Form S-1/A
04/02/2024
4:29 PM
Calidi Biotherapeutics (Filer)
Form S-1/A
04/01/2024
8:00 AM
Calidi Biotherapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/29/2024
8:47 PM
Calidi Biotherapeutics (Filer)
Form S-1/A
(Data available from 1/1/2016 forward)

Remove Ads

Related Companies and Tools


This page (NYSE:CLDI) was last updated on 3/30/2025 by MarketBeat.com Staff
From Our Partners